In vitro experiments showed that stimulating normal primary human lung fibroblasts with SSc-ILD serum and BAL fluids induce CXCL10 expression compared to controls and the IL-6 axis may be an alternative or parallel pathway for this activation. The gene discussed is IL6; the disease is systemic sclerosis.